Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
| ID | Título | Última Revisión | Siguiente Revisión | Descripción | Acceso |
|---|---|---|---|---|---|
| 11.001.004 | Marcadores de tumor sericos para cáncer de mama y gastrointestinal | Sep 21, 2016 | Policy Archived | ... | Ver |
| 11.001.005 | In Vitro Chemoresistance And Chemosensitivity Assays | Jul 03, 2025 | Policy Archived | In vitro chemoresistance and chemosensitivity assays have been developed to provide information about the... | Ver |
| 11.001.006 | Prueba de aliento de urea en el diagnóstico Helicobacter Pylori | Feb 10, 2025 | Policy Archived | Several invasive and non-invasive tests are available for the detection of helicobacter pylori infection in... | Ver |
| 11.001.007 | Identification Of Microorganisms Using Nucleic Acid Probes | Jul 10, 2025 | Jul 20, 2026 | Nucleic acid probes are available for the identification of a wide variety of microorganisms. nucleic acid... | Ver |
| 11.001.009 | Noninvasine Techniques For The Evaluation And Monitoring Of Patients With Chronic Liver Disease | Dec 12, 2024 | Dec 20, 2025 | Noninvasive techniques to monitor liver fibrosis are being investigated as alternatives to liver biopsy in... | Ver |
| 11.001.010 | Alfa-fetoproteina en la deteccion de cancer hepatocelular | May 12, 2016 | Policy Archived | ... | Ver |
| 11.001.011 | Serum Biomarker Human Epididymis Protein 4 | Jan 21, 2025 | Jan 20, 2026 | Human epididymis protein 4 (he4) is a novel biomarker that has been cleared by the u.s. food and drug... | Ver |
| 11.001.012 | Jak2 And Mpl, Testing For Myeloproliferative Neoplasms | Sep 11, 2025 | Sep 20, 2026 | Somatic (acquired) genetic variants in jak2, mpl, and calr genes have been implicated as the underlying... | Ver |
| 11.001.013 | Urinary Biomarkers For Cancer Screening, Diagnosis, And Surveillance | Jan 21, 2025 | Jan 20, 2026 | The diagnosis of bladder cancer is generally made by cystoscopy and biopsy. bladder cancer has a very high... | Ver |
| 11.001.016 | Serum Biomarker Tests For Multiple Sclerosis | Jul 03, 2025 | Policy Archived | Serum antibodies to polysaccharide-containing molecules, called glycans, and other serum biomarkers are... | Ver |
| 11.001.017 | Pharmacogenetic Testing For Pain Management | Feb 20, 2025 | Feb 20, 2026 | While multiple pharmacologic therapies are available for the management of acute and chronic pain, there is a... | Ver |
| 11.001.018 | Diagnóstico serológico de la enfermedad celiaca | Sep 21, 2016 | Policy Archived | ... | Ver |
| 11.001.020 | Detection Of Circulating Tumor Cells In The Management Of Patients With Cancer | May 30, 2019 | Policy Archived | The prognosis of cancer patients is often determined by the occurrence of metastatic disease. studies have... | Ver |
| 11.001.021 | Measurement Of Long-Chain Omega-3 Fatty Acids In Red Blood Cell Membranes As A Cardiac Risk Factor | Jul 03, 2025 | Policy Archived | Epidemiologic studies have reported that subjects who eat a diet high in fish have a reduced risk of sudden... | Ver |
| 11.001.022 | Homocysteine Testing In The Screening, Diagnosis, And Management Of Cardiovascular Disease And Venous Thromboembolic Disease | Jan 08, 2025 | Jan 20, 2026 | Homocysteine is an amino acid that has been evaluated as a potential marker of cardiovascular disease (cvd)... | Ver |
| 11.001.023 | Procalcitonin As A Marker In The Systemic Inflammatory Response | Nov 10, 2021 | Policy Archived | Severe infection and sepsis are frequent causes of morbidity and mortality in intensive care units. infection... | Ver |
| 11.001.024 | Laboratory Testing For Hiv Tropism | Jan 19, 2021 | Policy Archived | Hiv tropism testing can determine the predominant coreceptor protein used by hiv to infect target cells.... | Ver |
| 11.001.026 | Genotipo y Fenotipo en HIV | May 16, 2016 | Policy Archived | ... | Ver |
| 11.001.027 | Immune Cell Function Assay | Jan 08, 2025 | Jan 20, 2026 | Careful monitoring of lifelong immunosuppression is required to ensure the long-term viability of solid organ... | Ver |
| 11.001.029 | Prueba fibronectina fetal | May 16, 2016 | Policy Archived | ... | Ver |
